Eligible Debilitating Medical Conditions
Is the list of “debilitating medical conditions” limited? YES – As defined in section 121 of HRS-329 , a qualifying debilitating medical condition includes:
- Amyotrophic Lateral Sclerosis (added effective December 19, 2017 as per the petition process)
- Lupus (added effective June 29, 2017 as per Act 041, SHL 2017)
- Epilepsy (added effective June 29, 2017 as per Act 041, SHL 2017)
- Multiple Sclerosis (added effective June 29, 2017 as per Act 041, SHL 2017)
- Rheumatoid Arthritis (added effective June 29, 2017 as per Act 041, SHL 2017)
- Positive status for human immunodeficiency virus,
- Acquired immune deficiency syndrome,
- Post-traumatic stress disorder (added effective July 1, 2015 as per Act 241, SLH 2015), or
- “The treatment of these conditions”, or “A chronic or debilitating disease or medical condition or its treatment that produces one or more of the following:
- Cachexia or wasting syndrome,
- Severe pain,
- Severe nausea,
- Seizures, including those characteristic of epilepsy, or
- Severe and persistent muscle spasms, including those characteristic of multiple sclerosis or Crohn’s disease.
Has the list of debilitating medical conditions ever changed since the program began in 2000? YES – Act 241, SHL 2015 – Hawaii’s Dispensary Legislation, added post-traumatic stress disorder (PTSD) as a new condition effective July 1, 2015 and Act 041, SHL 2017 added lupus, epilepsy, multiple sclerosis, and rheumatoid arthritis effective June 29, 2017.
Amyotrophic Lateral Sclerosis (ALS) was added in 2017 through the petition process.
Is there a way to add a debilitating medical condition that is not currently stated in the law? YES – In the DOH Administrative Rules, Chapter 11-160, HAR, a process for department approved conditions has been outlined. See Petition Process for more information.